Big Move For Lipella Pharmaceuticals Inc.
Wed, Oct 18, 2023 at 07:23 PM
Lipella Pharmaceuticals Inc. (LIPO:NASDAQ) rocketted at $1.43, representing a gain of 45.9%. On Wed, Oct 18, 2023, LIPO:NASDAQ touched a New 2-Week High of $1.43. The stock appeared on our News Catalysts scanner on Thu, Sep 21, 2023 at 08:51 AM in the 'BIOTECH' category. From Wed, Oct 04, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
About Lipella Pharmaceuticals Inc. (LIPO:NASDAQ)
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company's lead product includes LP-10 and LP-310.
Top 10 Gainers:
- FBYD (FBYD:NASDAQ), 75.43%
- SeaStar Medical Inc Com (ICU:NASDAQ), 70.05%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 66.67%
- Shift Technologies Inc. (SFT:NASDAQ), 58.12%
- Golden Minerals Company (AUMN:NYSEMKT), 47.27%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 45.92%
- Treasure Global Inc. (TGL:NASDAQ), 39.42%
- PaxMedica Inc. (PXMD:NASDAQ), 34.62%
- Galera Therapeutics, Inc. (GRTX:NASDAQ), 34.51%
- Otonomo Technologies Ltd. (OTMO:NASDAQ), 32.5%